Literature DB >> 35006507

Low-Risk Non-mucinous Adenocarcinoma of the Appendix: When Is an Appendectomy Enough?

Kevin M Turner1, Sameer H Patel2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35006507     DOI： 10.1245/s10434-021-11229-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  3 in total

1.  Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience.

Authors:  Michael J Carr; James Sun; Danielle DePalo; Luke D Rothermel; Yun Song; Richard J Straker; Kristin Baecher; Raphael J Louie; Emma H A Stahlie; G Paul Wright; Syeda Mahrukh Hussnain Naqvi; Youngchul Kim; Amod A Sarnaik; Giorgos C Karakousis; Michael C Lowe; Keith A Delman; Alexander C J van Akkooi; David W Ollila; Frances Collichio; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2021-10-14       Impact factor: 5.344

2.  The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal Adenocarcinoma.

Authors:  Samer S AlMasri; Alessandro Paniccia; Abdulrahman Y Hammad; Reetesh K Pai; Nathan Bahary; Amer H Zureikat; David S Medich; James P Celebrezze; Haroon A Choudry; Ibrahim Nassour
Journal:  J Gastrointest Surg       Date:  2021-07-21       Impact factor: 3.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.